Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.685 USD | +2.74% | -10.10% | -42.62% |
11/04 | BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target | MT |
02/04 | HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.62% | 68.13M | |
-2.33% | 103B | |
+1.94% | 95.28B | |
+1.60% | 22.15B | |
-15.29% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-12.85% | 16.05B | |
+4.36% | 13.68B | |
+35.54% | 12.17B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Update: Sesen Bio Soars Ahead of FDA's Decision on Bladder Cancer Drug Application